Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
British journal of surgery2017Vol. 105(3), pp. 295–301
Citations Over TimeTop 10% of 2017 papers
Harald Grut, Steinar Solberg, Therese Seierstad, Mona Elisabeth Revheim, T Egge, Stein Gunnar Larsen, Pål‐Dag Line, Svein Dueland
Abstract
Patients treated by LT for unresectable CLM have a good prognosis following resection of pulmonary metastases. Doubling time did not appear to be worse with the immunosuppression used after LT.
Related Papers
- → Current Use of Immunosuppression in Liver Transplantation(2023)3 cited
- → Immunosuppression after pediatric liver transplant: The parents’ perspective(2023)3 cited
- → Posttransplant donor antigen-specific hyporeactivity in human transplantation(1995)11 cited
- Individual immunosuppression regime in liver transplant recipients with high risk factors(2003)
- → General Principle of Immunosuppression(2013)